These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 5827464)
61. [Tonsillar focal infections and ocular pathology. Clinico-statistical considerations]. Bernabei L; Carmi G; Dragoni GP Atti Accad Fisiocrit Siena Med Fis; 1964; 13(2):877-900. PubMed ID: 5865653 [No Abstract] [Full Text] [Related]
62. New dimensions in ocular pharmacology. Leopold IH Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(3):301-19. PubMed ID: 5333400 [No Abstract] [Full Text] [Related]
63. [Ascorbic acid in the treatment of eye diseases]. Mozherenkov VP; Agafonov BV Oftalmol Zh; 1980; 35(2):117-9. PubMed ID: 6995889 [No Abstract] [Full Text] [Related]
65. Successful use of Mydocalm in ophthalmology. Pál M Ther Hung; 1967; 15(3):123-6. PubMed ID: 6081647 [No Abstract] [Full Text] [Related]
66. [Irrigation system "Meturakol" in the treatment of dystrophic processes of the posterior eye segment]. Sidorenko EI; Podyninogin NV Vestn Oftalmol; 2000; 116(4):30-1. PubMed ID: 11031874 [TBL] [Abstract][Full Text] [Related]
67. [Biophysical considerations on eye spraying with iodosol concentrate]. Fulmek R Arch Phys Ther (Leipz); 1967; 19(2):151-5. PubMed ID: 5584766 [No Abstract] [Full Text] [Related]
68. [Treatment of certain cases of sciatica by the Lièvre method of transsacral infiltration]. Domljan Z; Androić S Reumatizam; 1970; 17(6):206-11. PubMed ID: 5204674 [No Abstract] [Full Text] [Related]
69. Sustained release intraocular drug delivery devices for treatment of uveitis. Haghjou N; Soheilian M; Abdekhodaie MJ J Ophthalmic Vis Res; 2011 Oct; 6(4):317-29. PubMed ID: 22454753 [TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetic considerations in the treatment of bacterial keratitis. Callegan MC; O'Callaghan RJ; Hill JM Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776 [TBL] [Abstract][Full Text] [Related]
71. Iontophoresis: a non-invasive ocular drug delivery. Eljarrat-Binstock E; Domb AJ J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678 [TBL] [Abstract][Full Text] [Related]
72. [Considerations on the use of corticoids by ionization in certain ocular diseases]. Lachaud JP Bull Soc Ophtalmol Fr; 1965 Jan; 65(1):84-9. PubMed ID: 5827464 [No Abstract] [Full Text] [Related]
73. [Therapy of eye diseases with Corti Biciron eye ointment]. Orou F Z Allgemeinmed; 1971 May; 47(14):772-3. PubMed ID: 4327069 [No Abstract] [Full Text] [Related]
74. [Drug electrophoresis in the overall treatment of the eye lesions in endocrine diseases]. Danilova AI Oftalmol Zh; 1980; 35(5):268-72. PubMed ID: 7422212 [No Abstract] [Full Text] [Related]